Literature DB >> 33509132

A predictive tool for the assessment of right ventricular dysfunction in non-high-risk patients with acute pulmonary embolism.

Yizhuo Gao1, Lianghong Chen2, Dong Jia3.   

Abstract

BACKGROUND: Rapid and accurate identification of right ventricular (RV) dysfunction is essential for decreasing mortality associated with acute pulmonary embolism (PE), particularly for non-high-risk patients without hypotension on admission. This study aimed to develop a rapid and accurate tool for predicting the risk of RV dysfunction in non-high-risk patients with acute PE.
METHODS: The medical records of non-high-risk patients with acute PE admitted to Shengjing Hospital of China Medical University between January 2011 and May 2020 were retrospectively analysed. The primary outcome of this study was RV dysfunction within 24 h after admission. The enrolled patients were randomized into training or validation sets as a ratio of 2:1. In the training set, a nomogram was developed, and the consistency was corroborated in the validation set. The areas under the receiver operating characteristic curves (AUCs) and 95% confidence intervals (CIs) were calculated.
RESULTS: A total of 845 patients were enrolled, including 420 men and 425 women with an average age of 60.05 ± 15.43 years. Right ventricular dysfunction was identified in 240 patients (28.40%). The nomogram for RV dysfunction included N-terminal pro-brain natriuretic peptide, cardiac troponin I, and ventricular diameter ratios, which provided AUC values of 0.881 in the training dataset (95% confidence interval (CI): 0.868-0.898, p < 0.001) and 0.839 in the validation set (95% CI: 0.780-0.897, p < 0.001). The predictive tool was published as a web-based calculato ( https://gaoyzcmu.shinyapps.io/APERVD/ ).
CONCLUSIONS: The combination of CT and laboratory parameters forms a predictive tool that may facilitate the identification of RV dysfunction in non-high-risk patients with acute PE.

Entities:  

Keywords:  Cardiac troponin I; Computerized tomography; N-terminal pro-brain natriuretic peptide; Pulmonary embolism; Pulmonary hypertension

Year:  2021        PMID: 33509132     DOI: 10.1186/s12890-020-01380-8

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  5 in total

1.  Improving risk prediction for pulmonary embolism in COVID-19 patients using echocardiography.

Authors:  Monika A Satoskar; Thomas Metkus; Alborz Soleimanifard; Julie K Shade; Natalia A Trayanova; Erin D Michos; Monica Mukherjee; Madeline Schiminger; Wendy S Post; Allison G Hays
Journal:  Pulm Circ       Date:  2022-03-08       Impact factor: 2.886

2.  Clinical Application of Echocardiography in Evaluating Left Ventricular Diastolic Function in Patients with Acute Pulmonary Embolism.

Authors:  Shiyang Qin; Rui Zhang
Journal:  Comput Math Methods Med       Date:  2022-05-11       Impact factor: 2.809

3.  Quantitative volumetric computed tomography embolic analysis, the Qanadli score, biomarkers, and clinical prognosis in patients with acute pulmonary embolism.

Authors:  Wei-Ming Huang; Wen-Jui Wu; Sheng-Hsiung Yang; Kuo-Tzu Sung; Ta-Chuan Hung; Chung-Lieh Hung; Chun-Ho Yun
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

4.  An Auxiliary Scoring Model for Patients with Acute Pulmonary Embolism Complicated with Atrial Fibrillation Was Established Based on Random Forests.

Authors:  Chuang Zhang; Qiongchan Guan; Jie Qin; Daochao Huang; Jinhong Wu
Journal:  Emerg Med Int       Date:  2022-08-22       Impact factor: 1.621

5.  Fully automatic cardiac four chamber and great vessel segmentation on CT pulmonary angiography using deep learning.

Authors:  Michael J Sharkey; Jonathan C Taylor; Samer Alabed; Krit Dwivedi; Kavitasagary Karunasaagarar; Christopher S Johns; Smitha Rajaram; Pankaj Garg; Dheyaa Alkhanfar; Peter Metherall; Declan P O'Regan; Rob J van der Geest; Robin Condliffe; David G Kiely; Michail Mamalakis; Andrew J Swift
Journal:  Front Cardiovasc Med       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.